{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:55:30Z","timestamp":1782996930657,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004948","name":"Astellas Pharma Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.bbrc.2023.04.103","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T21:06:05Z","timestamp":1684271165000},"page":"27-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Discovery and pharmacological characterization of novel positive allosteric modulators acting on skeletal muscle-type nicotinic acetylcholine receptors"],"prefix":"10.1016","volume":"668","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4271-8339","authenticated-orcid":false,"given":"Asako","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Chino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2023.04.103_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/science.abg6539","article-title":"Nicotinic acetylcholine receptor redux: discovery of accessories opens therapeutic vistas","volume":"373","author":"Matta","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2023.04.103_bib2","doi-asserted-by":"crossref","first-page":"11009","DOI":"10.1021\/bi00502a001","article-title":"Nicotinic acetylcholine receptor superfamily of ligand-gated ion channels","volume":"29","author":"Stroud","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2023.04.103_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020490","article-title":"Fundamental molecules and mechanisms for forming and maintaining neuromuscular synapses","volume":"19","author":"Burden","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2023.04.103_bib4","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1093\/hmg\/ddr396","article-title":"A\u00a0valid mouse model of AGRIN-associated congenital myasthenic syndrome","volume":"20","author":"Bogdanik","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2023.04.103_bib5","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1093\/hmg\/ddh333","article-title":"MUSK, a new target for mutations causing congenital myasthenic syndrome","volume":"13","author":"Chevessier","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2023.04.103_bib6","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/hmg\/ddt578","article-title":"LRP4 third beta-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner","volume":"23","author":"Ohkawara","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2023.04.103_bib7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/14728222.2017.1369960","article-title":"Agrin-LRP4-MuSK signaling as a therapeutic target for myasthenia gravis and other neuromuscular disorders","volume":"21","author":"Ohno","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbrc.2023.04.103_bib8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.mcn.2008.12.011","article-title":"Truncated dystrophins can influence neuromuscular synapse structure","volume":"40","author":"Banks","year":"2009","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbrc.2023.04.103_bib9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fnana.2016.00006","article-title":"Neuromuscular junctions as key contributors and therapeutic targets in spinal muscular atrophy","volume":"10","author":"Boido","year":"2016","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.bbrc.2023.04.103_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.exger.2010.03.007","article-title":"Remodeling of the neuromuscular junction precedes sarcopenia related alterations in myofibers","volume":"45","author":"Deschenes","year":"2010","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.bbrc.2023.04.103_bib11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","article-title":"Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man","volume":"185","author":"Fischer","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbrc.2023.04.103_bib12","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbrc.2023.04.103_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419832242","article-title":"Understanding the burden of refractory myasthenia gravis","volume":"12","author":"Schneider-Gold","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.bbrc.2023.04.103_bib14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis - autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbrc.2023.04.103_bib15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.neuron.2005.04.002","article-title":"Neurotransmitter acetylcholine negatively regulates neuromuscular synapse formation by a Cdk5-dependent mechanism","volume":"46","author":"Lin","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2023.04.103_bib16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm.2618","article-title":"Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseases","volume":"18","author":"Russell","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2023.04.103_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13690","article-title":"Chloride channel inhibition improves neuromuscular function under conditions mimicking neuromuscular disorders","volume":"233","author":"Pedersen","year":"2021","journal-title":"Acta Physiol."},{"key":"10.1016\/j.bbrc.2023.04.103_bib18","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.bcp.2007.07.011","article-title":"Allosteric modulation of nicotinic acetylcholine receptors","volume":"74","author":"Bertrand","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2023.04.103_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108008","article-title":"Advances in the in\u00a0vitro and in\u00a0vivo pharmacology of Alpha4beta2 nicotinic receptor positive allosteric modulators","volume":"168","author":"Wilkerson","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbrc.2023.04.103_bib20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1124\/mol.111.074302","article-title":"Investigation of the molecular mechanism of the alpha7 nicotinic acetylcholine receptor positive allosteric modulator PNU-120596 provides evidence for two distinct desensitized states","volume":"80","author":"Williams","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2023.04.103_bib21","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.bcp.2013.05.018","article-title":"Effects of neuronal nicotinic acetylcholine receptor allosteric modulators in animal behavior studies","volume":"86","author":"Pandya","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2023.04.103_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172916","article-title":"Alpha 7 nicotinic receptor agonist and positive allosteric modulators improved social and molecular deficits of MK-801 model of schizophrenia in rats","volume":"193","author":"Unal","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbrc.2023.04.103_bib23","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/bph.13745","article-title":"Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors","volume":"175","author":"Wang","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2023.04.103_bib24","doi-asserted-by":"crossref","first-page":"9436","DOI":"10.1073\/pnas.90.20.9436","article-title":"Molecular dissection of subunit interfaces in the acetylcholine receptor: identification of residues that determine curare selectivity","volume":"90","author":"Sine","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2023.04.103_bib25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1476-5381.2012.01989.x","article-title":"Augmentation of cognitive function by NS9283, a stoichiometry-dependent positive allosteric modulator of alpha2- and alpha4-containing nicotinic acetylcholine receptors","volume":"167","author":"Timmermann","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2023.04.103_bib26","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/gt.2011.44","article-title":"CDK4 and cyclin D1 allow human myogenic cells to recapture growth property without compromising differentiation potential","volume":"18","author":"Shiomi","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.bbrc.2023.04.103_bib27","first-page":"e158","article-title":"Single-nucleus RNA-seq of differentiating human myoblasts reveals the extent of fate heterogeneity","volume":"44","author":"Zeng","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2023.04.103_bib28","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1039\/D1LC00048A","article-title":"Development of a human neuromuscular tissue-on-a-chip model on a 24-well-plate-format compartmentalized microfluidic device","volume":"21","author":"Yamamoto","year":"2021","journal-title":"Lab Chip"},{"key":"10.1016\/j.bbrc.2023.04.103_bib29","doi-asserted-by":"crossref","first-page":"C366","DOI":"10.1152\/ajpcell.1982.242.5.C366","article-title":"Influence of presynaptic receptors on neuromuscular transmission in rat","volume":"242","author":"Wilson","year":"1982","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbrc.2023.04.103_bib30","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1476-5381.1986.tb14594.x","article-title":"Mechanisms of the inhibition by neostigmine of tetanic contraction in the mouse diaphragm","volume":"87","author":"Chang","year":"1986","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2023.04.103_bib31","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.4049\/jimmunol.178.8.5390","article-title":"Amelioration of experimental autoimmune myasthenia gravis in rats by neonatal FcR blockade","volume":"178","author":"Liu","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2023.04.103_bib32","first-page":"5","volume":"F1000Res","author":"Phillips","year":"2016"},{"key":"10.1016\/j.bbrc.2023.04.103_bib33","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.ajpath.2011.10.031","article-title":"Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis","volume":"180","author":"Mori","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2023.04.103_bib34","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s12035-014-8887-2","article-title":"Synaptic pathophysiology and treatment of lambert-eaton myasthenic syndrome","volume":"52","author":"Tarr","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbrc.2023.04.103_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088739","article-title":"Injection of a soluble fragment of neural agrin (NT-1654) considerably improves the muscle pathology caused by the disassembly of the neuromuscular junction","volume":"9","author":"Hettwer","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2023.04.103_bib36","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34375","article-title":"Preserving neuromuscular synapses in ALS by stimulating MuSK with a therapeutic agonist antibody","volume":"7","author":"Cantor","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.bbrc.2023.04.103_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101385","article-title":"DOK7 gene therapy enhances neuromuscular junction innervation and motor function in aged mice","volume":"23","author":"Ueta","year":"2020","journal-title":"iScience"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2300534X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2300534X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:29:28Z","timestamp":1757766568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2300534X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":37,"alternative-id":["S0006291X2300534X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.04.103","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and pharmacological characterization of novel positive allosteric modulators acting on skeletal muscle-type nicotinic acetylcholine receptors","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.04.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}